|
2024
|
Invention
|
Combination of a cdk inhibitor and a flt3 inhibitor for the treatment of cancer. The disclosure h... |
|
2023
|
Invention
|
Combination therapies. Provided herein are methods of treating and sensitizing cancer comprising ... |
|
|
Invention
|
Combination therapy of pi3k inhibitor and pd-1 inhibitor.
Provided herein are methods ... |
|
|
Invention
|
Combination therapy of pi3k inhibitor and pd-1 inhibitor. Provided herein are methods of treating... |
|
|
Invention
|
Isoflavonoid compounds and methods for the treatment of cancer.
Provided herein is a pharmaceuti... |
|
2022
|
Invention
|
(alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimi... |
|
|
Invention
|
Combination therapy.
Provided herein are methods of treating diseases, such as cancer, using a c... |
|
|
Invention
|
Voruciclib dosing regimens and methods of treatment including the same.
The present disclosure r... |
|
|
Invention
|
Voruciclib dosing regimens and methods of treatment including the same. The present disclosure re... |
|
|
Invention
|
Combination therapy. Provided herein are methods of treating diseases, such as cancer, using a co... |
|
2021
|
Invention
|
Treatment of kras mutant cancers.
The disclosure herein provides combination therapies for the t... |
|
|
Invention
|
Treatment of kras mutant cancers. The disclosure herein provides combination therapies for the tr... |
|
|
G/S
|
pharmaceutical products for the treatment of cancer and immune-related diseases and disorders; ph... |
|
|
Invention
|
Combination therapies. Provided herein are compositions, methods, and kits for treating cancer co... |
|
|
Invention
|
Preparation of a 1,3,5-triazinyl benzimidazole.
Described herein is the preparation of a 1,3,5-t... |
|
|
Invention
|
Preparation of a 1,3,5-triazinyl benzimidazole. Described herein is the preparation of a 1,3,5-tr... |
|
2020
|
Invention
|
Combination therapies.
Provided herein are methods of treating and sensitizing cancer comprising... |
|
|
Invention
|
Voruciclib polymorphs and methods of making and using thereof. The disclosure relates to crystall... |
|
|
Invention
|
Voruciclib poly morphs and methods of making and using thereof. The disclosure relates to crystal... |
|
|
Invention
|
Polymorphic forms of 3-[2-butyl-1-(2-diethylamino-ethyl)-1h-benzoimidazol-5-yl]-n-hydroxy-acrylam... |
|
2019
|
Invention
|
Combination therapies for high and very high risk mds.
Provided herein are methods of treating h... |
|
|
Invention
|
Combination therapies for high and very high risk mds. Provided herein are methods of treating hi... |
|
|
Invention
|
Treatment of b cell malignancies.
Provided herein are methods of treating cancer using a phospho... |
|
|
Invention
|
Treatment of relapsed follicular lymphoma.
Provided herein are methods treating follicular lymph... |
|
|
Invention
|
Treatment of relapsed follicular lymphoma. Provided herein are methods treating follicular lympho... |
|
|
Invention
|
Treatment of b cell malignancies. Provided herein are methods of treating cancer using a phosphoi... |
|
2018
|
Invention
|
Benzimidazole derivatives: preparation and pharmaceutical applications. The present invention rel... |
|
2017
|
Invention
|
Polymorphic forms of 3-[(2-butyl-1-(2-diethylamino-ethyl)-1h-benzoimidazol-5-yl]-n-hydroxy-acryla... |
|
|
Invention
|
Polymorphic forms of 3-[2-butyl-1-(2-diethylamino-ehtyl)-1h-benzoimidazol-5-yl]-n-hydroxy-acrylam... |
|
2016
|
Invention
|
Substituted chroman derivatives, medicaments and use in therapy.
Novel substituted chroman deriv... |
|
2015
|
Invention
|
Chroman derivatives, medicaments and use in therapy.
Novel chroman derivatives and intermediate ... |
|
|
Invention
|
Substituted chroman derivatives, medicaments and use in therapy. Novel substituted chroman deriva... |
|
2012
|
G/S
|
Pharmaceuticals for use in the treatment of oncological disorders, neurological disorders, and im... |
